Investigating the immune kinetics of COVID-19 vaccine responses between European and African populations
The purpose of this study is to understand immune response to the COVID-19 vaccine. This research study is led by Yemaachi Biotech Ltd, in partnership with Ghana Health Service, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Francis Crick Institute, and Bill & Melinda Gates Foundation.
You may participate in this study if you:
- Are 18 years or older
- have not yet been vaccinated for COVID-19
Participation consists of 7 visits* to your vaccination site over 12 months, which would involve:
- COVID-19 testing
- 2 doses of AstraZeneca or Pfizer COVID-19 vaccine
- Blood sample collection
- Answering questions about your experiences following your COVID-19 vaccinations.